July 2023 HCPCS Updates

CMS has released the July 2023 Healthcare Common Procedure Coding System (HCPCS) File. Inclusion on this list does not indicate coverage. All HCPCS code changes are effective and should be used for claims with dates of service on or after July 1, 2023. Please watch the Noridian website for additional policy updates regarding HCPCS codes.

Added HCPCS Codes

Effective for dates of service on and after July 1, 2023

HCPCS Description
J0137 Injection, acetaminophen (hikma) not therapeutically equivalent to j0131, 10 mg
J0206 Injection, allopurinol sodium, 1 mg
J0216 Injection, alfentanil hydrochloride, 500 micrograms
J0457 Injection, aztreonam, 100 mg
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg
J0736 Injection, clindamycin phosphate, 300 mg
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1805 Injection, esmolol hydrochloride, 10 mg
J1806 Injection, esmolol hydrochloride (wg critical care) not therapeutically equivalent to j1805, 10 mg
J1811 Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
J1812 Insulin (fiasp), per 5 units
J1813 Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
J1814 Insulin (lyumjev), per 5 units
J1836 Injection, metronidazole, 10 mg
J1920 Injection, labetalol hydrochloride, 5 mg
J1921 Injection, labetalol hydrochloride (hikma) not therapeutically equivalent to j1820, 5 mg
J1941 Injection, furosemide (furoscix), 20 mg
J1961 Injection, lenacapavir, 1 mg
J2249 Injection, remimazolam, 1 mg
J2305 Injection, nitroglycerin, 5 mg
J2329 Injection, ublituximab-xiiy, 1mg
J2371 Injection, phenylephrine hydrochloride, 20 micrograms
J2372 Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
J2427 Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
J2561 Injection, phenobarbital sodium (sezaby), 1 mg
J2598 Injection, vasopressin, 1 unit
J2599 Injection, vasopressin (american regent) not therapeutically equivalent to j2598, 1 unit
J2806 Injection, sincalide (maia) not therapeutically equivalent to j2805, 5 micrograms
J9029 Injection, nadofaragene firadenovec-vncg, per therapeutic dose
J9056 Injection, bendamustine hydrochloride (vivimusta), 1 mg
J9058 Injection, bendamustine hydrochloride (apotex), 1 mg
J9059 Injection, bendamustine hydrochloride (baxter), 1 mg
J9063 Injection, mirvetuximab soravtansine-gynx, 1 mg
J9259 Injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg
J9322 Injection, pemetrexed (bluepoint) not therapeutically equivalent to j9305, 10 mg
J9323 Injection, pemetrexed (hospira) not therapeutically equivalent to j9305, 10 mg
J9347 Injection, tremelimumab-actl, 1 mg
J9350 Injection, mosunetuzumab-axgb, 1 mg
J9380 Injection, teclistamab-cqyv, 0.5 mg
J9381 Injection, teplizumab-mzwv, 5 mcg
Q5131 Injection, adalimumab-aacf (idacio), biosimilar, 20 mg

 

Deleted HCPCS Code

Invalid for billing for dates of service July 1, 2023 and after

HCPCS Description
J2370 INJECTION, PHENYLEPHRINE HCL, UP TO 1 ML

 

Description Update

The long description of the HCPCS code has been updated as of July 1, 2023

HCPCS Description
J2426 Injection, paliperidone palmitate extended release (invega sustenna), 1 mg

 

Last Updated Jun 13 , 2023